Shares of Insulet (NASDAQ: PODD) were up 15.3% this week as of the market close on Thursday, according to data from S&P Global Market Intelligence. The big jump came following a report that Dexcom (NASDAQ: DCOM) and Insulet are in discussions about a potential merger. Investors clearly see the prospects of a merger with Dexcom as positive for Insulet.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting